drugset / Trial / NCT03848039

Impact on Disease Relapse of HPV Vaccination in Women Treated With LEEP for Cervical Intraepithelial Neoplasia. HOPE9

NCT03848039

Phase 3 Not yet recruiting 1220 enrolled Alessandro Ghelardi
RandomizedParallel-groupDouble-blindPrevention

Summary

This study evaluates the impact on disease relapse of presurgical 9-valent HPV vaccination versus placebo vaccination in women treated with LEEP (loop electrosurgical excision procedure) for CIN2+ (high grade cervical intraepithelial neoplasia) and initially invasive cervical cancer.

Timeline

Start
2020-12
Primary completion
2022-12
Completion
2028-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Gardasil 9 Vaccine Intramuscular